logo

Stock Screener

Forex Screener

Crypto Screener

VEEV

Veeva Systems Inc. (VEEV)

$

290.86

+8.58 (2.95%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

7.3960

Market cap

Market cap

46.4 Billion

Price to sales ratio

Price to sales ratio

16.2547

Debt to equity

Debt to equity

0.0124

Current ratio

Current ratio

4.6049

Income quality

Income quality

1.5419

Average inventory

Average inventory

0

ROE

ROE

0.1374



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Veeva Systems Inc. delivers cloud-based software solutions tailored for the life sciences sector across North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company reported depreciation and amortization expenses of $39,383,000.00 reflecting the wear and tear of its assets. Furthermore, it earned an interest income of $207,987,000.00 showcasing its financial investments. The EBITDA is $730,818,000.00 a key indicator of the company's operational profitability, and all financial data pertains to the fiscal year 2025. Additionally, the company incurred an interest expense of $0.00 reflecting its debt servicing obligations. Veeva offers a comprehensive Veeva Commercial Cloud suite, which encompasses a variety of software, data, and analytics solutions like Veeva customer relationship management (CRM) and Veeva Medical CRM, alongside tools such as Veeva CLM, Veeva CRM MyInsights, Veeva CRM Approved Email, Veeva CRM Engage, and Veeva Align, among others. It also provides Veeva Vault for enterprise content and data management, facilitating the management of commercial functions including sales, marketing, medical communications, and research areas such as clinical, regulatory, quality, and safety processes. The company supports clients with professional services that encompass implementation planning, project management, solution design, systems integration, and ongoing managed services, which include outsourced administration. The stock is priced at $282.28 positioning it in the higher-end market, and it boasts a high average trading volume of 1,426,696.00 indicating strong liquidity. With a mid-range market capitalization of $47,530,014,320.00 the company is a steady performer in its field. As a key player in the Medical - Healthcare Information Services industry, Veeva Systems contributes significantly to the overall market landscape and belongs to the Healthcare sector, driving innovation and growth. The diverse range of solutions offered underscores its commitment to advancing the life sciences field, making it an essential partner for organizations aiming to enhance their operational efficiencies and deliver impactful results. Veeva Systems Inc., formerly known as Verticals onDemand, Inc., has established itself since its incorporation in 2007 and continues to thrive with its headquarters in Pleasanton, California.

What is Veeva Systems Inc. (VEEV)'s current stock price?

The current stock price of Veeva Systems Inc. (VEEV) is $290.86 as of 2025-08-22. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Veeva Systems Inc. (VEEV) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.

Analysts predict Veeva Systems Inc. stock to fluctuate between $197.01 (low) and $296.72 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-08-22, Veeva Systems Inc.'s market cap is $47,530,014,320, based on 163,412,000 outstanding shares.

Compared to Nvidia Corp, Veeva Systems Inc. has a Lower Market-Cap, indicating a difference in performance.

To buy Veeva Systems Inc. (VEEV) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for VEEV. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.

Revenue: $2,746,619,000 | EPS: $4.41 | Growth: 34.86%.

Visit https://www.veeva.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $343.96 (2021-08-05) | All-time low: $151.02 (2022-10-14).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

VEEV

prnewswire.com

Leaders Come Together to Advance the Industry at Veeva Summit

Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction Veeva to showcase innovations, including deep industry-specific Veeva AI in Vault Platform and Veeva applications PLEASANTON, Calif. , Aug. 21, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced highlights of its upcoming Veeva R&D and Quality Summit, where leaders across life sciences and Veeva exchange impactful ideas and innovations.

VEEV

zacks.com

Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

VEEV

zacks.com

Veeva Systems (VEEV) Exceeds Market Returns: Some Facts to Consider

Veeva Systems (VEEV) concluded the recent trading session at $279.18, signifying a +1.36% move from its prior day's close.

VEEV

zacks.com

Reasons to Add Veeva Systems Stock to Your Portfolio for Now

VEEV's strong first quarter, product innovations and strategic deals drive growth prospects despite rising costs.

VEEV

prnewswire.com

Research Shows Medtechs Prioritizing Site Collaboration and Data Quality

Nearly 70% say reducing manual processes is a key priority for working with sites PLEASANTON, Calif. , Aug. 12, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced findings from the 2025 Veeva MedTech Clinical Benchmark, showing that medtech clinical teams are focused on streamlining work with research sites to reduce manual processes (68%), improve study quality (56%), and gain greater visibility and oversight (55%).

VEEV

zacks.com

Veeva Systems (VEEV) Declines More Than Market: Some Information for Investors

Veeva Systems (VEEV) closed at $279.76 in the latest trading session, marking a -1.02% move from the prior day.

VEEV

zacks.com

VEEV Volumes Double: Will Philip Morris' E-Vapor Bet Pay Off?

PM's VEEV shipments have more than doubled in the second quarter, with Europe driving growth and new markets showing early promise.

VEEV

zacks.com

Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition?

VEEV leans on Vault R&D for growth as AI-native rivals rise, testing its edge in clinical and regulatory innovation.

VEEV

zacks.com

Here's Why Veeva Systems (VEEV) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

VEEV

zacks.com

Veeva Systems (VEEV) Beats Stock Market Upswing: What Investors Need to Know

Veeva Systems (VEEV) reached $291.25 at the closing of the latest trading day, reflecting a +1.83% change compared to its last close.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener